After Market Gainers - Stocks Telegraph

OLB GROUP TO CONDUCT FOURTH QUARTER AND 2023 ANNUAL REPORT CALL TODAY, APRIL 15

News

new york, ny / accesswire / april 15, 2024 / the olb group, inc. (nasdaq:olb), a diversified fintech ecommerce merchant services provider and bitcoin mining enterprise, will conduct an earnings conference call on april 15, 2024 at 4:30 pm eastern daylight time. shareholders and interested investors are invited to participate in the company's earnings call.

APPARENT CSLR SHORT ATTACK JUST AFTER ISSUING OPTIONS

News

fremont, calif., april 18, 2024 (globe newswire) -- complete solaria, inc. (“complete solaria” or the “company”) (nasdaq: cslr) today released an internal document which describes what appears to be a short attack on its stock on the trading day after it launched and announced its first major employee stock option program.

MOBILE-HEALTH NETWORK SOLUTIONS RANKED NUMBER 41 IN FINANCIAL TIMES LISTING OF 500 HIGH-GROWTH ASIA-PACIFIC COMPANIES

News

singapore, april 17, 2024 (globe newswire) -- mobile-health network solutions (nasdaq: mndr ), a leading telehealth solutions provider in singapore, today announced that the company has been ranked number 41 in the financial times annual listing of 500 high-growth asia-pacific companies. the listing , published march 13, was based on the company's revenue growth between 2019 and 2022.

T2 BIOSYSTEMS SHAREHOLDERS VOTE FOR CRG DEBT CONVERSION INTO EQUITY

News

lexington, mass., april 11, 2024 (globe newswire) -- t2 biosystems, inc. (nasdaq:ttoo), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced results from the special meeting of stockholders on april 11, 2024. t2 biosystems stockholders voted for the approval of conversion of $15 million of its term loan with entities affiliated with crg servicing llc (“crg”) into t2 biosystems equity.

MGO GLOBAL ANNOUNCES 2023 YEAR-END RESULTS

News

new stand flagpoles' business helps to achieve 411% in year-over-year revenue growth miami, fl, new york, ny and london, uk / accesswire / april 3, 2024 / mgo global inc. (nasdaq:mgol), a digitally-native, lifestyle brand portfolio company, ("mgo" or the "company" or "mgo global"), today announced its financial results for the year ended december 31, 2023. maximiliano ojeda, co-founder, chairman and ceo of mgo global, stated, "i am pleased to report that we finished 2023 on a strong note, with our new stand flagpole business delivering solid revenue performance and the messi store demonstrating notable double-digit growth.

GOLDEN HEAVEN GROUP HOLDINGS LTD. ENTERS INTO A COLLABORATION AGREEMENT WITH NANPING CITY DACHENG CULTURE COMMUNICATION CO., LTD.

News

nanping, china , april 2, 2024 /prnewswire/ -- golden heaven group holdings ltd. (the "company" or "golden heaven") (nasdaq: gdhg), an amusement park operator in china, today announced that on march 29, 2024, it entered into a collaboration agreement (the "agreement") with nanping city dacheng culture communication co., ltd.

GALERA REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND RECENT CORPORATE UPDATES

News

company continues to evaluate strategic options to maximize shareholder value company continues to evaluate strategic options to maximize shareholder value

SUPERCOM TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON APRIL 22, 2024

News

tel aviv, israel , april 18, 2024 /prnewswire/ -- supercom (nasdaq: spcb), a global provider of secured solutions for the e-government, iot and cybersecurity sectors, will hold a conference call on monday, april 22, 2024, at 8:30 a.m. eastern time (5:30 a.m.

INNOVATIVE EYEWEAR, INC. SIGNS UK FOOTBALL LEGEND AND MEDIA PERSONALITY MICAH RICHARDS AS BRAND AMBASSADOR

News

miami , april 18, 2024 /prnewswire/ -- innovative eyewear, inc. ("innovative eyewear" or the "company") (nasdaq: lucy; lucyw), the developer of chatgpt smart eyewear under the lucyd®, nautica®, eddie bauer® and reebok® brands, today announced the signing of micah richards as an official brand ambassador. micah richards is a former england international footballer, turned successful broadcaster, currently working for sky sports, cbs sports and bbc sport while he is also a co-host of "the rest is football" – a top ten uk podcast.

SIMPPLE LTD. ANNOUNCES CLOSING OF US$8.4 MILLION INITIAL PUBLIC OFFERING

News

singapore, sept. 15, 2023 (globe newswire) -- simpple ltd. (nasdaq: sppl) (the “company” or “simpple”), an advanced technology solution provider in the emerging property-technology (“proptech”) space, today announced the closing of its initial public offering (the “offering”) of 1,602,000 ordinary shares at a public offering price of us$5.25 per ordinary share. the ordinary shares began trading on september 13, 2023 under the ticker symbol “sppl”.

QUANTUM PROVIDES ADDITIONAL BUSINESS UPDATES

News

san jose, calif.--(business wire)--quantum corporation (nasdaq: qmco), a leader in solutions for ai and unstructured data, provided additional updates on its business. fiscal fourth quarter 2024 liquidity update quantum's unaudited cash and long-term debt balances as of march 31, 2024, are provided below: cash and cash equivalents were $26.1 million. outstanding term loan debt was $87.9 million, outstanding borrowings under the revolving credit facility was $26.6 million, total interest expense.

SURF AIR MOBILITY RECEIVES CONTINUED LISTING STANDARD NOTICE FROM NYSE

News

los angeles--(business wire)--surf air mobility inc. (nyse: srfm) (“surf air mobility”,“surf air”), a leading regional air mobility platform, today announced that on april 2, 2024 it received notice from the new york stock exchange (“nyse”) that it is not in compliance with section 802.01c of the nyse listed company manual because the average closing price of surf air's common stock was less than $1.00 over a consecutive 30 trading-day period. the nyse notice has no immediate impact on the list.

PRESTIGE WEALTH INC. ANNOUNCES FIRST HALF OF FISCAL YEAR 2023 FINANCIAL RESULTS

News

hong kong , dec. 1, 2023 /prnewswire/ -- prestige wealth inc. (nasdaq: pwm) (the "company" or "prestige wealth"), a wealth management and asset management services provider based in hong kong, today announced its unaudited financial results for the six months ended march 31, 2023. mr. hongtao shi, the company's chairman and chief executive officer, commented, "reflecting upon the first half of fiscal year 2023, we faced some undeniable headwinds in our wealth management business, largely stemming from the ramifications of the covid-19 pandemic.

CHINA PHARMA HOLDINGS INC. ANNOUNCES 1-FOR-5 REVERSE STOCK SPLIT

News

haikou, china , feb. 23, 2024 /prnewswire/ -- china pharma holdings inc. ("china pharma" or the "company") (nyse american: cphi) reported that it expects to implement a 1-for-5 reverse stock split on its common stock effective wednesday, march 6, 2024, with trading to begin on a split-adjusted basis at the market open on that day. trading in the common stock will continue on the nyse american under the symbol "cphi".

EMCORE REPORTS FISCAL 2024 FIRST QUARTER RESULTS

News

alhambra, ca, feb. 08, 2024 (globe newswire) -- emcore corporation (nasdaq: emkr), the world's largest independent provider of inertial navigation solutions to the aerospace and defense industry, today announced results for the fiscal 2024 first quarter (1q24) ended december 31, 2023. management will host a conference call to discuss 1q24 financial and business results on february 8, 2024 at 5:00 p.m.

AMERICAN REBEL REPORTS FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023

News

nashville, tn, april 16, 2024 (globe newswire) -- american rebel holdings, inc. (nasdaq: areb) ("american rebel" or the "company"), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and american rebel beer ( americanrebelbeer.com ), announced its financial results for the year ended december 31, 2023. investors are encouraged to read the company's annual report on form 10-k, which was filed with the securities and exchange commissions (the “sec”) and contains additional information and is posted at https://americanrebel.com/investor-relations .

SOLECTRAC ANNOUNCES STRATEGIC REORGANIZATION TO FURTHER AMPLIFY ELECTRIFICATION EFFORTS AND ENHANCE CUSTOMER SUPPORT

News

ideanomics' electric tractor subsidiary will leverage success to date in its direct-to-customer business by expanding the dtc strategy and partnering with a curated dealer network in key markets ideanomics' electric tractor subsidiary will leverage success to date in its direct-to-customer business by expanding the dtc strategy and partnering with a curated dealer network in key markets

GRAPHJET TECHNOLOGY PUBLISHES PRESENTATION ON INVESTOR WEBSITE

News

kuala lumpur, malaysia, april 02, 2024 (globe newswire) -- graphjet technology (“graphjet” or “the company”), the first and only developer of patented technologies to produce graphite and graphene directly from agricultural waste, today announced that an investor presentation is now available on the company's website. investors, analysts, and interested stakeholders are invited to access the replay through the "news & events" section of the company's website at https://www.graphjettech.com/.

BONE BIOLOGICS ANNOUNCES CLOSING OF $2.0 MILLION PUBLIC OFFERING

News

burlington, mass.--(business wire)--bone biologics corporation (“bone biologics” or the “company”) (nasdaq: bblg, bblgw), a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced public offering of an aggregate of 781,251 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 781,251 shares of common stock, at a public offering price of $2.56 per share (or common stock equivalent in l.

CALIDI BIOTHERAPEUTICS, INC. ANNOUNCES CLOSING OF $6.1 MILLION PUBLIC OFFERING

News

san diego--(business wire)---- $cldi #immunotherapy--calidi biotherapeutics, inc. announces closing of $6.1 million public offering.

SU GROUP SUCCESSFULLY IMPLEMENTS VIRTUAL CALL CENTER TO SUPPORT GROWTH

News

hong kong , april 15, 2024 /prnewswire/ -- su group holdings limited (nasdaq: sugp) ("su group" or the "company"), an integrated security-related engineering services company in hong kong, today announced it has successfully implemented a virtual call center ("vcc") to support its business growth and further expansion. the advanced system was customized to su group's technical specifications and will provide a superior experience to its customers and partners as well as increase their operational efficiency.

EKSO BIONICS RECEIVES FINAL PAYMENT DETERMINATION FOR MEDICARE REIMBURSEMENT FROM THE CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS) FOR EKSO INDEGO PERSONAL

News

san rafael, calif., april 12, 2024 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (the “company” or “ekso bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the pricing, data analysis, and coding (“pdac”) contractor for the centers for medicare & medicaid services (“cms”) has determined a final payment level of $91,031.93 for medicare reimbursement of the ekso indego personal, which took effect on april 1, 2024.

OPTINOSE TO PRESENT AT THE NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

News

yardley, pa., april 04, 2024 (globe newswire) -- optinose (nasdaq:optn), a pharmaceutical company focused on patients treated by ear, nose and throat (ent) and allergy specialists, today announced that members of its management team will present a company overview and business update at the needham virtual healthcare conference on april 10, 2024 at 2:15 p.m. et.

WANG & LEE GROUP, INC. ANNOUNCES FISCAL YEAR 2023 FINANCIAL RESULTS

News

hong kong, china, april 18, 2024 (globe newswire) -- wang & lee group, inc. (nasdaq: wlgs) (“wlgs” or the “company”), is a british virgin islands holding company with operations conducted by its subsidiaries in hong kong. the company is a construction prime and subcontractor engaging in the installation of electrical & mechanical systems (“e&m”), which include low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning (“mvac”) systems, fire service systems, water supply and sewage disposal system installation and fitting out for the public and private sectors. the company today announced its unaudited operating results for the year ended december 31, 2023.

AS EXPECTED, TUPPERWARE BRANDS RECEIVES NYSE NOTICE REGARDING LATE 2023 10-K FILING

News

orlando, fla. , april 19, 2024 /prnewswire/ -- tupperware brands corporation (nyse: tup) (the "company") announced today the status of its filing of its 2023 financial statements.

NATIONWIDE INSURANCE TO SHOWCASE HOW THEY ARE DRIVING PROACTIVE RISK MANAGEMENT USING ILEARNINGENGINES' ENTERPRISE AI PLATFORM AT THE 2024 INSURANCE INNOVATORS CONFERENCE

News

presentation dives deep into the ways ai technology is reshaping the effectiveness of risk management for the insurance industry presentation dives deep into the ways ai technology is reshaping the effectiveness of risk management for the insurance industry

ASSURE HOLDINGS CLOSES SALE OF CERTAIN ASSETS TO MPOWERHEALTH

News

denver, march 28, 2024 (globe newswire) -- assure holdings corp. (the “company” or “assure”) (nasdaq: ionm), a provider of intraoperative neuromonitoring (“ionm”) and remote neurology services, today announced that it closed the sale of certain assets of its ionm business to mpowerhealth on march 26, 2024. the sale includes proceeds of up to $4.5 million, of which $2.32 million was paid in cash at the initial closing and up to an additional $2.18 million to be paid in relation to a potential earnout payment tied to case volume from the acquired assets during the 12-month period following the initial closing. the asset sale includes most of the company's healthcare facility contracts and clinical equipment, and a majority of the company's employees. the company retains certain of its assets, including but not limited to, its accounts receivable and its employees in the revenue cycle management team.

MARINE PETROLEUM TRUST ANNOUNCES FIRST QUARTER CASH DISTRIBUTION

News

dallas , feb. 16, 2024 /prnewswire/ -- marine petroleum trust (nasdaq: marps) ("marine") today declared a quarterly cash distribution to the holders of its units of beneficial interest of $0.101611 per unit, payable on march 28, 2024, to unitholders of record on february 29, 2024. marine's 2023 tax information, cash distribution history, current and prior year financial reports, a link to filings made with the securities and exchange commission and more can be found on its website at http://www.marps-marine.com/.

NETCAPITAL ANNOUNCES THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS

News

boston--(business wire)---- $ncpl #earnings--netcapital inc. (nasdaq: ncpl, ncplw) (the “company”), a digital private capital markets ecosystem, today announced select financial results for the third quarter of fiscal year 2024 ended january 31, 2024. "despite the challenges faced by businesses seeking capital in the current market climate, we remain optimistic about our future prospects and the strength of our funding portal,” said martin kay, ceo of netcapital inc. "while we experienced a decline in the number o.

BLUE STAR FOODS SECURES ADDITIONAL NON-DILUTIVE GROWTH CAPITAL TO SUPPORT EXPANSION OF BUSINESS UNDER EXISTING MASTER SERVICE AGREEMENT & SOFT SHELL CRAB OPERATIONS

News

miami, fl, april 17, 2024 (globe newswire) -- blue star foods corp., (“blue star,” the “company,” “we,” “our” or “us”) (nasdaq: bsfc ), an integrated environmental, social, and governance (esg) sustainable seafood company with a focus on recirculatory aquaculture systems (ras), today announced it has secured additional funding to help meet increased demand under its previously announced master service agreement as well as increase the volume in its soft shell crab operations.

CHIMERIX REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

News

durham, n.c., april 16, 2024 (globe newswire) -- chimerix (nasdaq:cmrx) today announced that on april 10, 2024, the compensation committee of chimerix's board of directors granted inducement awards to four new employees of non-statutory stock options to purchase up to a total of 223,000 shares of chimerix's common stock. the compensation committee of chimerix's board of directors approved the awards as an inducement material to the new employees' employment in accordance with nasdaq listing rule 5635(c)(4).

LATE-BREAKING DATA HIGHLIGHTING BENEFITS OF ULTRAFILTRATION THERAPY USING THE AQUADEX SYSTEM FOR HEART FAILURE PATIENTS WAS PRESENTED AT THE TECHNOLOGY AND HEART FAILURE THERAPEUTICS CONFERENCE

News

- analysis demonstrates the statistically superior benefits of ultrafiltration therapy in heart failure events and heart failure hospitalizations compared to intravenous loop diuretics-  artificial intelligence and machine learning-based model show that lifestyle and clinical factors can be strong predictors of heart failure events

HEMPACCO ANNOUNCES IT HAS REGAINED COMPLIANCE WITH NASDAQ LISTING RULE 5550(A)(2)

News

san diego, california--(newsfile corp. - march 28, 2024) - hempacco co., inc. (nasdaq: hpco) ("hempacco" or the "company"), a vertically integrated hemp manufacturing company, announces its recent achievement of regaining compliance with nasdaq's minimum bid price requirement. this milestone was confirmed in a letter received from nasdaq on march 26, 2024, marking a pivotal moment for the company's financial health and stock market presence.

CIDARA THERAPEUTICS PRESENTS PROMISING NEW DATA ON NOVEL DRUG-FC CONJUGATE CANDIDATES AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING 2024

News

- multispecific cd73/pd-1 dfc demonstrates improved tumor reduction compared to pd-1 monotherapy in nonclinical study - ccr5-targeting dfc demonstrates potent efficacy in colorectal cancer mouse model - late-breaking cbo421 data demonstrates improved efficacy compared to oleclumab in human triple-negative breast cancer cell lines san diego, april 05, 2024 (globe newswire) -- cidara therapeutics, inc. (nasdaq: cdtx), a biotechnology company using its proprietary cloudbreak® platform to develop drug-fc conjugate (dfc) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, announced the company will deliver four poster presentations, including one late-breaking poster presentation, at this year's american association for cancer research (aacr) annual meeting being held april 5-10, 2024 at the san diego convention center in san diego, california. the presentations highlight data on the company's multispecific cd73/pd-1 drug fc-conjugate (dfc), its ccr5-targeting dfc, and cbo421, its lead oncology dfc candidate targeting cd73.

GOSSAMER BIO ANNOUNCES APPOINTMENT OF STEVEN D. NATHAN, M.D.

News

san diego--(business wire)--gossamer bio, inc. (nasdaq: goss), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (pah) and pulmonary hypertension associated with interstitial lung disease (ph-ild), today announced the appointment of steven d. nathan, m.d., and skye drynan to its board of directors. dr. nathan is medical director of inova's advanced lung disease program and lung transpla.

BANZAI EXPANDS REACH SOLUTION

News

seattle, march 07, 2024 (globe newswire) -- banzai international, inc. (nasdaq: bnzi), a leading marketing technology company that provides essential marketing and sales solutions, today announced an expansion of reach , its event marketing solution. this expansion includes the creation of an operating business unit, investment in new technology systems to support customers more efficiently, and an expanded strategic focus within banzai to serve additional customers.

HUADI INTERNATIONAL GROUP CO., LTD. ANNOUNCES FISCAL YEAR 2023 FINANCIAL RESULTS

News

beijing , feb. 6, 2024 /prnewswire/ -- huadi international group co., ltd. ("hudi" or the "company") (nasdaq: hudi), a leading developer and manufacturer of industrial stainless steel seamless pipes and tubes products in china, today announced its financial results for the fiscal year ended september 30, 2023.

CROWN ELECTROKINETICS CORP. REPORTS YEAR END 2023 FINANCIAL RESULTS AND REVISES GUIDANCE

News

los angeles, ca / accesswire / april 1, 2024 / crown electrokinetics corp. (nasdaq:crkn) ("crown" or the "company"), ("crown" or the "company a leading smart glass technology company and an expert in constructing fiber optic networks, today announced its year-end 2023 financial results. financial results for the year ended december 31, 2023 compared to 2022 net loss: net loss for the year ended december 31, 2022, was $29.0 million this included $9.7 million of non-cash other expense primarily related to the balance sheet restructuring crown executed in the first half of 2023.

ZK INTERNATIONAL RECEIVES NASDAQ NOTICES REGARDING LISTING DEFICIENCY

News

wenzhou, china , feb. 22, 2024 /prnewswire/ -- zk international group co., ltd. (nasdaq: zkin) ("zkin," "zk international" or the "company"), a leading provider of advanced steel products, announced that it received the nasdaq notices regarding minimum bid requirements and not timely filing of annual report on form 20-f on february 15, 2024, the company received a written notice from the listing qualifications department of the nasdaq stock market, llc ("nasdaq") notifying the company that, based on the closing bid price of the company's ordinary shares, no par value (the "ordinary shares"), for the last 30 consecutive trading days, the company no longer complies with the minimum bid price requirement for continued listing on the nasdaq capital market.

ELEDON PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2023 OPERATING AND FINANCIAL RESULTS

News

enrolled 12 participants in phase 2 bestow trial evaluating tegoprubart for the prevention of kidney rejection tegoprubart used as a component of the immunosuppressive treatment regimen following the first-ever transplant of a kidney from a genetically modified pig to a human additional data from 11 participants in phase 1b trial in kidney transplantation demonstrated that tegoprubart was generally safe and well tolerated, successfully prevented rejection and permitted above historical average post-transplant kidney function irvine, calif., march 28, 2024 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn) today reported its fourth quarter and full year 2023 operating and financial results and reviewed recent business highlights.

STRONGHOLD PROVIDES MARCH 2024 BITCOIN MINING AND OPERATIONAL UPDATE

News

new york, april 09, 2024 (globe newswire) -- stronghold digital mining, inc. (nasdaq: sdig) (“stronghold” or the “company”) today provided the following updates regarding its operations and financial performance:

BOMBAS TEAMS WITH TABOOLA TO DRIVE 300% RETURN ON AD SPEND USING TABOOLA'S PERFORMANCE ADVERTISING-FOCUSED BIDDING TECHNOLOGY CALLED MAXIMIZE CONVERSIONS

News

new york, april 17, 2024 (globe newswire) -- taboola (nasdaq: tbla), a global leader in powering recommendations for the open web, today announced the results of a successful holiday advertising campaign with comfort-focused apparel brand bombas , driving 300% return on ad spend (roas) in november 2023.

PALISADE BIO SUCCESSFULLY DEMONSTRATES BIOACTIVATION OF PALI-2108 IN EX-VIVO STUDY OF NORMAL HEALTHY AND ULCERATIVE COLITIS PATIENTS' STOOL

News

company continues advancing ongoing development of targeted therapies for ulcerative colitis (uc) carlsbad, ca, april 16, 2024 (globe newswire) -- palisade bio, inc.  (nasdaq: pali) (“palisade”, “palisade bio” or the “company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, announced today the successful completion of its analysis evaluating ex-vivo bioactivation of pali-2108, an orally administered, locally acting colon-specific phosphodiesterase-4 (pde4) inhibitor prodrug in development for patients affected by uc. these findings demonstrated that pali-2108 exhibited efficient ex-vivo conversion into its active pde4 inhibitor form in stool samples from both normal healthy volunteers and patients with uc.

FIREFLY NEUROSCIENCE ANNOUNCES HEALTHCARE SCIENCE AND AI INDUSTRY LEADER DAVID DECAPRIO TO JOIN BOARD OF DIRECTORS

News

board appointment is a key step towards anticipated trading on nasdaq board appointment is a key step towards anticipated trading on nasdaq

ATLASCLEAR, INC. TO PARTICIPATE IN LD MICRO CONFERENCE ON APRIL 9

News

tampa, fla.--(business wire)--atlasclear holdings, inc. (“atlasclear holdings”) (nyse: atch) today announced that chief strategy officer, john schaible and chief business development officer, craig ridenhour, will be presenting at the ld micro conference on tuesday, april 9, 2024 at 9:00 am et. a live webcast of the presentation will be available on the atlasclear investor relations website at https://investors.atlasclear.com under the “events & presentations” section and archived for a lim.

OHMYHOME REPORTS 2023 FULL-YEAR RESULTS

News

ohmyhome achieves s$5.0 million 2023, launches homerai and completes acquisition of its property management business, and is poised for 3x growth in 2024 and a positive adjusted ebitda in q4 2024

AXCELIS ANNOUNCES TIMING AND AVAILABILITY OF FIRST QUARTER 2024 RESULTS AND CONFERENCE CALL

News

beverly, mass. , april 11, 2024 /prnewswire/ -- axcelis technologies, inc. (nasdaq: acls) will release financial results for the first quarter of 2024 on wednesday, may 1, 2024, at 4:00 p.m.

ORGANOVO ANNOUNCES POSITIVE PHASE 2 RESULTS FOR FXR314 IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) SHOWING BOTH REDUCTION IN LIVER FAT CONTENT AND STRONG SAFETY AND TOLERABILITY COMPARED TO PLACEBO

News

organovo announces positive phase 2 results for fxr314 in metabolic dysfunction-associated steatohepatitis (mash) showing both reduction in liver fat conte

STARBOX GROUP HOLDINGS LTD. ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2023

News

kuala lumpur, malaysia , feb. 8, 2024 /prnewswire/ -- starbox group holdings ltd. (nasdaq: stbx) ("starbox" or the "company"), a service provider of cash rebates, advertising, and payment solutions, has unveiled its financial results for the fiscal year ended september 30, 2023.

NLS PHARMACEUTICS ANNOUNCES CLOSING OF $1.75 MILLION REGISTERED DIRECT OFFERING

News

zürich, switzerland / accesswire / march 22, 2024 / nls pharmaceutics ltd. (nasdaq:nlsp)(nasdaq:nlspw) ("nls" or the "company"), a swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced the closing of its previously announced registered direct offering of 7,000,000 of its common shares at a purchase price of $0.25 per share.

RELIANCE GLOBAL GROUP'S REVENUE GROWS BY 17% AND 40% IN 2023 COMPARED TO 2022 AND 2021, RESPECTIVELY

News

acquisition letter of intent previously announced progresses to final stages of definitive agreement discussions acquisition letter of intent previously announced progresses to final stages of definitive agreement discussions

ISPECIMEN REPORTS FULL YEAR 2023 RESULTS

News

lexington, mass., march 14, 2024 (globe newswire) -- ispecimen inc.  (nasdaq: ispc) (“ispecimen” or the “company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the twelve-month period ended december 31, 2023.

AGBA/TRILLER $4 BILLION MERGER: ELEVATING SHAREHOLDER VALUE TO NEW HEIGHTS - IMMEDIATELY AND FOR THE LONG TERM

News

los angeles, april 19, 2024 (globe newswire) -- nasdaq-listed, agba group holding limited (“agba”), has previously announced that on april 16, 2024, it had entered into a definitive merger agreement (the “merger agreement”) to combine agba with triller corp. (“triller”), a leading artificial intelligence-driven social video platform (together, the “merger” or the “transaction”). upon completion of the transaction, agba will become a delaware corporation that wholly owns triller, and agba itself will be majority-owned (80%) by current triller stockholders and restricted stock unit (“rsu”) holders.

PHOENIX MOTOR EXPECTS TO REPORT $14 MILLION TO $16 MILLION REVENUE IN Q2 2024

News

anaheim, ca / accesswire / april 18, 2024 / phoenix motor inc. (nasdaq:pev), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced its revenue guidance for the second quarter of 2024. the company expects to report revenue in the range of $14 million to $16 million, representing a significant increase from the $1.8 million recorded in the first quarter of 2023 and up from the expected $8 million to $9 million forecasted for q1 2024, the company's previous record revenue quarter.

AIRSHIP AI REPORTS FULL YEAR 2023 FINANCIAL RESULTS

News

fy 2023 revenue of $12.3 million with pipeline of $140 million expected to drive triple-digit revenue growth and positive cash flow in fy 2024 backlog increased to $11.8 million driven by demand from fortune 500 customers, and u.s. federal government and department of defense agencies with strong focus on advanced technologies for enhanced border protection completed merger and began trading as a public company on nasdaq under “aisp” on december 22, 2023 redmond, wash., april 01, 2024 (globe newswire) -- airship ai holdings, inc. (nasdaq: aisp) (“airship ai” or the “company”), a leader in ai-driven video, sensor, and data management surveillance solutions, today reported its financial and operational results for the full year ended december 31, 2023.

ENVIVA RECEIVES NYSE NOTICE REGARDING DELAYED FORM 10-K FILING

News

bethesda, md. , april 8, 2024 /prnewswire/ -- enviva inc. (nyse: eva) ("enviva" or the "company") today announced that on april 2, 2024, the company received notice from the new york stock exchange (the "nyse") that it is not in compliance with section 802.01e of the nyse listed company manual due to a delay in filing its annual report on form 10-k for the year ended december 31, 2023, with the securities and exchange commission (the "sec").

DARÉ BIOSCIENCE ANNOUNCES PUBLICATION IN CONTRACEPTION OF POSITIVE EFFICACY AND SAFETY FINDINGS FROM A PRE-PIVOTAL POSTCOITAL TEST STUDY OF OVAPRENE®: AN INVESTIGATIONAL HORMONE-FREE MONTHLY INTRAVAGINAL CONTRACEPTIVE

News

published data shows that ovaprene was safe and effective in a postcoital test study of 33 women pivotal phase 3 contraceptive efficacy clinical study of ovaprene currently enrolling ovaprene has the potential to be the first fda-approved hormone-free monthly intravaginal contraceptive for women san diego, april 11, 2024 (globe newswire) -- daré bioscience, inc. (nasdaq: dare), a leader in women's health innovation, today announced the publication of data from the postcoital test clinical study of ovaprene in two original research articles in the journal contraception. publication details: mauck, et al.

SMARTER LOGISTICS FILES LAWSUIT AGAINST REAL GOOD FOODS FOR UNPAID SERVICES

News

coral springs, florida--(newsfile corp. - april 13, 2024) - smarter logistics has taken legal action against real good foods, filing a lawsuit in the superior court of new jersey, camden county, under docket number cam-l-983-24. this action comes after a prolonged dispute over unpaid services, raising significant concerns about real good foods' financial practices and its impact on vendors and the logistics sector.

BIOCARDIA REPORTS FOURTH QUARTER AND FULL YEAR 2023 BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS

News

sunnyvale, calif., march 27, 2024 (globe newswire) -- biocardia®, inc. [nasdaq: bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended december 31, 2023 and filed its annual report on form 10-k with the securities and exchange commission.

DATCHAT UNLEASHES AI DOG RACING AND FULL MONETIZATION IN HABYTAT METAVERSE EXPANSION

News

company's social media ecosystem grows with new update to habypets ai-powered game new brunswick, nj, feb. 29, 2024 (globe newswire) -- datchat (nasdaq: dats), a secure messaging, social media, and metaverse company, today announced a significant enhancement to its habytat metaverse with the release of its ai dog racing. this latest update introduces a comprehensive monetization across the habytat platform, showcasing video ads and in-world purchases.

AKOUSTIS SECURES DESIGN WIN AND VOLUME ORDERS FOR WI-FI 7 SOLUTION WITH TIER-1 ENTERPRISE CLASS OEM

News

charlotte, n.c., april 08, 2024 (globe newswire) -- akoustis technologies, inc. (nasdaq: akts) (“akoustis” or the “company”), an integrated device manufacturer (idm) of patented bulk acoustic wave (baw) high-band rf filters for mobile and other wireless applications, announced today that high-performance narrowband patented xbaw® filters are being designed into a new program with an enterprise-class original equipment manufacturer (oem).

EXPION360 ANNOUNCES SUBSTANTIAL PREORDERS OF NEXT GENERATION LITHIUM BATTERIES NOW FEATURING VERTICAL HEAT CONDUCTION™ HEATING TECHNOLOGY

News

redmond, ore., april 18, 2024 (globe newswire) -- expion360 inc. (nasdaq: xpon) (“expion360” or the “company”), an industry leader in lithium-ion battery power storage solutions, today announced substantial preorders of its next generation group 27 and gc2 batteries that now include its groundbreaking vertical heat conduction™ (“vhc™”) internal heating technology, a patent-pending innovation representing a significant breakthrough in battery performance, particularly in cold climates, will now be included in the next generation group 27 and gc2 series.

BIOLASE REPORTS FULL-YEAR 2023 RESULTS; EXPECTS CONTINUED REVENUE GROWTH IN 2024

News

lake forest, ca / accesswire / march 21, 2024 / biolase, inc. (nasdaq:biol), the globally recognized leader in dental laser technology, who previously announced its preliminary financial results for the fourth quarter and full year ended december 31, 2023, today reported its financial results for the quarter and full year. 2023 full-year highlights achieved revenue growth despite industry headwinds and a challenging interest rate environment throughout 2023.

ADDENTAX GROUP CORP. AND DEZHONG XINGHUI COLLABORATE TO DEVELOP AI LOGISTIC SYSTEM, FACILITATING BREAKTHROUGHS IN LOGISTICS DELIVERY

News

shenzhen, china , march 20, 2024 /prnewswire/ -- addentax group corp. ("addentax" or the "company") (nasdaq: atxg), an integrated service provider focusing on garment manufacturing, logistics services, property management, and subleasing, has announced the formalization of a strategic cooperation and the signing of a three year memorandum of understanding (the "mou") with dezhong xinghui information technology co., ltd. ("dezhong xinghui") on march 20, 2024, an enterprise established in september 2017 based in hangzhou city's xihu district, is recognized for its high-tech innovations in digital retail.

ROSEN, TOP RANKED GLOBAL COUNSEL, ENCOURAGES CHECKPOINT THERAPEUTICS, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION - CKPT

News

new york , april 19, 2024 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of checkpoint therapeutics, inc. (nasdaq: ckpt) between march 10, 2021 and december 15, 2023, both dates inclusive (the "class period"), of the important june 4, 2024 lead plaintiff deadline. so what: if you purchased checkpoint securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

MONEYHERO GROUP HOSTS SINGAPORE'S LARGEST PERSONAL FINANCE FESTIVAL FOR SEVENTH STRAIGHT YEAR

News

the iconic annual event, which was held on april 6 th and is produced by seedly, the company's market-leading platform in singapore, drew over 5,000 attendees featured speakers included: dr. tan see leng, singapore's minister for manpower and second minister for trade and industry; mr. nelson neo, head of financial planning advisory & head of posb, dbs bank; and nearly 70 other notable names from across singapore's financial, insurance, and government landscapes moneyhero partnered with 35-plus major banking institutions and insurance providers in singapore for the 2024 festival—including cimb bank, citibank, dbs bank, manulife, posb bank and singlife dr. tan see leng, singapore's minister for manpower and second minister for trade and industry (left) speaks at seedly personal finance festival 2024.

EIGHTCO ANNOUNCES PRODUCT EXPANSION IN FOREVER 8'S APPLE PRODUCTS BUSINESS

News

easton, pa, april 17, 2024 (globe newswire) -- eightco holdings inc. (nasdaq: octo) (the “company” or “eightco”), today announced that its subsidiary, forever 8 fund llc (“forever 8”), is expanding the products for which it will provide inventory capital. in addition to operating in the broader e-commerce market, forever 8 is already a significant player in the refurbished smartphone market, providing inventory capital for sellers in the space, largely focused on the apple iphone. due to customer demand, forever 8 is now expanding its product offering into other refurbished apple products including ipads, airpods, the apple watch and the ipad pencil.

SONOMA PHARMACEUTICALS ANNOUNCES EXPANSION OF NEGATIVE-PRESSURE WOUND THERAPY PRODUCTS FOR USE IN THE UNITED STATES

News

boulder, co / accesswire / april 9, 2024 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced the expansion of its microcyn® negative-pressure wound therapy (npwt) solution products in the united states. microcyn negative-pressure wound therapy solution, an innovation in advanced wound care, is now available in convenient sizes of 250ml, 450ml, and 990ml.

PHUNWARE REPORTS FULL YEAR 2023 FINANCIAL RESULTS

News

austin, texas, march 12, 2024 (globe newswire) -- phunware, inc.  (nasdaq: phun) (“phunware” or “the company”), the leading provider of patented wayfinding and mobile engagement solutions for mobile that enables brands to engage, manage and monetize anyone anywhere, today announced financial results for the year ended december 31, 2023.

VUZIX WHOLLY OWNED SUBSIDIARY MOVIYNT PARTNERS WITH NETLOGISTIK TO OFFER MOBILITY SOLUTIONS FOR THE WAREHOUSE

News

rochester, n.y. , april 16, 2024 /prnewswire/ -- vuzix® corporation (nasdaq: vuzi), ("vuzix" or, the "company"), a leading supplier of smart glasses and augmented reality (ar) technology and products, today announced that moviynt, its wholly owned subsidiary and sap certified erp saas logistics solution provider, has established a referral partnership with netlogistik, a leader in powerful services that guide companies toward the digital transformation of the supply chain.

WISA STRIKES GAME-CHANGING FIFTH WISA E LICENSING DEAL WITH GLOBAL CONSUMER ELECTRONICS LEADER

News

beaverton, ore.--(business wire)--wisa strikes game-changing fifth wisa e licensing deal with global consumer electronics leader.

CLEARSIGN TECHNOLOGIES CORPORATION ANNOUNCES PRICING OF $9.3 MILLION PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT OF COMMON STOCK AND WARRANTS

News

tulsa, okla. , april 19, 2024 /prnewswire/ -- clearsign technologies corporation (nasdaq: clir) ("clearsign" or the "company"), an emerging leader in industrial combustion and sensing technologies that improve energy, operational efficiency and safety while dramatically reducing emissions, today announced the pricing of an underwritten public offering of 4,620,760 shares of its common stock and redeemable warrants to purchase up to an aggregate of 4,620,760 shares of its common stock at a public offering price of $0.91 per share and $0.01 per accompanying warrant.

AIM IMMUNOTECH ANNOUNCES RELEASE OF THE NEXT CEO CORNER SEGMENT

News

ocala, fla., april 18, 2024 (globe newswire) -- aim immunotech inc. (nyse american: aim) (“aim” or the “company”), today announced the next ceo corner segment has been published on the company's website. for the ceo corner segment, thomas equels, chief executive officer of aim immunotech, gave an overview of locally advanced pancreatic adenocarcinoma and the unmet need.

ALIGOS THERAPEUTICS PRESENTS POSITIVE CLINICAL DATA AT APASL 2024 FROM ALG-055009 AND ALG-000184 PHASE 1 STUDIES

News

south san francisco, calif., march 27, 2024 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs, “aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced three oral presentations and one poster presentation at the 33rd annual meeting of the asian pacific association for the study of the liver (apasl) 2024, being held march 27-31, 2024 in kyoto, japan.

SONIM REPORTS 34% INCREASE IN FY2023 REVENUE, TO $93.6 MILLION, SIGNIFICANT EXPANSION MOMENTUM IN NEW ADDRESSABLE MARKETS

News

expanding portfolio and carrier awards boost company's addressable market from $400m to $52b [*] 13 new carrier awards set to fuel 2024 product sales new 2024 product launches support entry into larger rugged pro, connected solutions and consumer markets, geographic expansion into europe san diego, california--(newsfile corp. - march 27, 2024) - sonim technologies, inc. (nasdaq: sonm), a leading provider of mobility solutions that include ultra-rugged and rugged phones, connected devices, consumer durable mobile devices, and accessories designed to provide extra protection for users that demand more durability in their work and everyday lives, reported financial results for the year ended december 31, 2023. full year 2023 and recent highlights net revenues increased by 34% year-over-year, to $93.6 million, up from $69.8 million in 2022 gaap net loss for the full year improved to $90 thousand, down from a net loss of $14.1 million in 2022 adjusted ebitda[†] was positive $4.0 million for 2023, compared to negative $9.9 million for 2022 ended the year with cash and cash equivalents totaling $9.4 million, accounts receivable at $25.3 million, and inventory valued at $6.5 million increased sales of sonim's fully refreshed xp10 ultra-rugged 5g smartphone at tier-one carriers in the u.s. and canada entered much larger adjacent wireless internet and consumer durable addressable markets with new devices set to launch throughout 2024 secured six awards each for wireless internet solutions and rugged phones, plus one for consumer durables with new devices set to launch beginning 2024 in target geographical markets commenced expansion plans to enter the european market, by establishing a geographic team focused on rugged mobility and connected solutions to fill the gap left by exiting competitors peter liu, sonim's chief executive officer, said: "in 2023, sonim achieved significant growth with a 34% increase in sales, improvement of the gaap net loss to $90 thousand, $4.0 million in positive adjusted ebitda, and three quarters of positive gaap net income, highlighting the early success of our strategy to grow and diversify.

TALKSPACE TO REPORT FIRST QUARTER 2024 AND HOST CONFERENCE CALL

News

new york, april 17, 2024 (globe newswire) -- talkspace (nasdaq: talk), a leading behavioral healthcare company, will release its first quarter 2024 results on tuesday, may 7, 2024, before market open and host a conference call to review the results at 8:30 a.m. et.

BUTTERFLY NETWORK TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 1, 2024

News

burlington, mass. & new york--(business wire)--butterfly network, inc. (nyse: bfly) (“butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report first quarter 2024 financial results on may 1, 2024, after the market closes. joseph devivo, president, chief executive officer and chairman of the board, and heather getz, executive vice president and chief financial and operations officer, will host a conference call and webcast at 5:00.

NOVABAY PHARMACEUTICALS REPORTS PRELIMINARY EYECARE AND WOUND CARE REVENUE INCREASED 13% FOR THE FIRST QUARTER OF 2024 ON LOWER SALES AND MARKETING EXPENSES

News

emeryville, calif.--(business wire)--novabay® pharmaceuticals, inc. (nyse american: nby) reports preliminary net revenue for its eyecare and wound care business for the first quarter of 2024 of $2.6 million, a 13% increase from the first quarter of 2023. this increase was achieved with lower sales and marketing expenses, and is attributed primarily to social media marketing programs aimed at consumer sales of the company's lead product, avenova antimicrobial lid & lash solution. “we started.

ASPEN AEROGELS, INC. SCHEDULES FIRST QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL

News

northborough, mass., april 11, 2024 /prnewswire/ -- aspen aerogels, inc. (nyse: aspn) ("aspen" or the "company") today announced that don young, president & chief executive officer, and ricardo c.

LONGEVERON RAISES A TOTAL OF $11.4 MILLION IN GROSS PROCEEDS FROM WARRANT EXERCISE OFFERING AND PUBLIC OFFERING

News

miami, april 18, 2024 (globe newswire) -- longeveron inc. (nasdaq: lgvn) (“longeveron” or the “company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (hlhs), alzheimer's disease and aging-related frailty, today announced the closing of its previously announced exercise of certain existing warrants to purchase an aggregate of 2,399,744 shares of its class a common stock having an exercise price of $2.35 per share, originally issued in october 2023 and april 2024. the issuance or resale of the shares of class a common stock issuable upon exercise of the existing warrants, as applicable, are registered pursuant to effective registration statements on form s-1 (file nos.

LEONARDO DRS RECOGNIZED WITH PRESTIGIOUS AWARD FOR REVOLUTIONARY INFRARED SENSOR

News

arlington, va.--(business wire)--leonardo drs, inc. (nasdaq: drs) announced today that it has been recognized with the prestigious 2024 herschel award for the development of a groundbreaking cooled infrared sensor that unlocks the ability for advanced military and scientific capabilities across multiple domains, including space. the award was presented by the military sensing symposium materials and detectors specialty group. the 2024 award recognized drs's work in developing the linear mode hg.

CCSC TECHNOLOGY INTERNATIONAL HOLDINGS LIMITED REPORTS FINANCIAL RESULTS FOR THE FIRST SIX MONTHS OF FISCAL YEAR 2024

News

hong kong , feb. 23, 2024 /prnewswire/ -- ccsc technology international holdings limited (the "company" or "ccsc") (nasdaq: cctg), a hong kong-based company that engages in the sale, design and manufacturing of interconnect products, including connectors, cables and wire harnesses, today announced its unaudited financial results for the first six months of fiscal year 2024 ended september 30, 2023. mr. kung lok chiu, chief executive officer and director of the company, commented, "during the first six months of fiscal year 2024, amidst macroeconomic uncertainties and rising supply chain costs, our revenue and gross profit decreased from the same period of last year; however, our gross margin remained stable despite the challenging environment.

TRANSCODE THERAPEUTICS ANNOUNCES FDA CLEARANCE TO INITIATE PHASE 1/2 CLINICAL TRIAL WITH TTX-MC138 IN PATIENTS WITH ADVANCED SOLID TUMORS

News

boston, april 15, 2024 (globe newswire) -- transcode therapeutics, inc. (nasdaq: rnaz), the rna oncology company committed to more effectively treating cancer using rna therapeutics, announced today that the u.s. food and drug administration (fda) has completed its review of the company's investigational new drug (ind) application and concluded that the company may proceed with its phase 1/2 multicenter, open-label, dose-escalation and dose-expansion study of its lead therapeutic candidate, ttx-mc138, in patients with advanced solid tumors. “we are thrilled to have obtained fda authorization to advance ttx-mc138 into the clinic.

MOMENTUS AND ASCENT SOLAR TECHNOLOGIES PARTNER TO BRING TO MARKET LEADING-EDGE SOLAR ARRAYS

News

san jose, calif.--(business wire)--momentus inc. (nasdaq: mnts) (“momentus”) and ascent solar technologies (nasdaq: asti) (“asti”) today announced a new partnership to jointly market leading-edge solar arrays utilizing the low-cost tape spring solar array (tassa) being developed by momentus and the high performance of ascent's flexible, lightweight photovoltaic modules. the rapid growth in the production and deployment of thousands of satellites in space has led to the burgeoning need for low-c.

NOVO INTEGRATED SCIENCES REPORTS FISCAL YEAR 2024 SECOND QUARTER FINANCIAL RESULTS

News

bellevue, wash.--(business wire)---- $nvos #aapi--novo integrated sciences reports fiscal year 2024 second quarter financial results.

SADOT GROUP INC. REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS

News

2023 revenue rises to $726.7 million from $161.7 million in 2022 adjusted ebitda rises to $0.1 million vs. $2.0 million loss year over year engages third party to explore the potential divestment of its restaurant and food prep assets fort worth, tx / accesswire / march 20, 2024 / sadot group inc. (nasdaq:sdot) (the "sadot group" or the "company"), an emerging player in the global food supply chain sector, today announced that it disclosed its full year results for the period ending december 31, 2023.

THE LAW OFFICES OF FRANK R. CRUZ ANNOUNCES INVESTIGATION OF SMARTRENT, INC. (SMRT) ON BEHALF OF INVESTORS

News

los angeles--(business wire)--the law offices of frank r. cruz announces an investigation of smartrent, inc. (“smartrent” or the “company”) (nyse: smrt) on behalf of investors concerning the company's possible violations of federal securities laws. if you are a shareholder who suffered a loss, click here to participate. on september 8, 2023, bleeker street research published a report alleging, among other things, that the "smart" locks that smartrent distributes "to large multi-family propertie.

BAKKT REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS

News

alpharetta, ga.--(business wire)--bakkt holdings, inc. (“bakkt”) (nyse: bkkt) announced its financial and operational results for the quarter and full year ended december 31, 2023. “bakkt has built a robust foundation and we are in a prime position as we enter the next phase of our journey to commercialize our platform and scale our business,” said andy main, incoming president and chief executive officer of bakkt. “our focus for 2024 is on a set of strategic initiatives that will provide our b.

ISUN, INC. ANNOUNCES APPOINTMENT OF ROBERT J. ZULKOSKI AS CHIEF EXECUTIVE OFFICER

News

williston, vt.--(business wire)--isun, inc. (nasdaq: isun) (the "company," or "isun"), a leading solar energy and clean mobility infrastructure company with 50-years of experience accelerating the adoption of innovative electrical technologies, today announced the appointment of robert j. (bob) zulkoski as chief executive officer. effective immediately, bob zulkoski is appointed as the new chief executive officer of isun, inc. jeff peck will remain full-time with isun in a strategic advisory an.

NOCO-NOCO AND NEOGEN FORGE STRATEGIC PARTNERSHIP TO UNLEASH X-SEPA™ TECHNOLOGY IN INDIA'S BURGEONING BATTERY MARKET (PROJECTED TO EXCEED US$16 BILLION BY 2031)

News

singapore, march 08, 2024 (globe newswire) --   highlights: neogen secured a 3-year marketing and distribution license for noco-noco's x-sepa™ technology with the eventual objective to manufacture x-sepatm separators in india. the combined technological synergies blending noco-noco's revolutionary x-sepa™ separator technology with neogen's electrolyte, will provide pioneering solutions to a wider clientele.

EXPONENTIAL HEALTH PARTNERS WITH CARDIO DIAGNOSTICS TO ELEVATE CARDIOVASCULAR DISEASE PREVENTION IN MICHIGAN

News

chicago--(business wire)--exponential health adopts cardio diagnostics' ai-driven epigenetic-genetic tests marking a new era in personalized and preventive cardiac care.

CNS PHARMACEUTICALS REPORTS FULL YEAR 2023 FINANCIAL RESULTS AND HIGHLIGHTS RECENT CORPORATE AND CLINICAL ACHIEVEMENTS

News

lead program, berubicin, successfully passed pre-planned interim futility analysis milestone with recommendation from dsmb to proceed without modification in potentially pivotal gbm study berubicin study enrollment completed; topline data expected in first half of 2025 clinical progress represents important steps towards berubicin potentially addressing the most aggressive type of brain cancer with an average survival of only 14 to 16 months after diagnosis and no cure houston, tx / accesswire / april 1, 2024 / cns pharmaceuticals, inc. (nasdaq:cnsp) ("cns" or the "company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today reported its financial results for the full year ended december 31, 2023 and outlined recent corporate and clinical development highlights. john climaco, ceo of cns pharmaceuticals, stated, "there remains a tremendous unmet medical need for an effective treatment for gbm, and we are dedicated to advancing this important program forward to bring much needed hope for patients.

HEARTSCIENCES TO PRESENT AT THE LD MICRO INVITATIONAL XIV CONFERENCE

News

southlake, tx, april 02, 2024 (globe newswire) -- heart test laboratories, inc. d/b/a heartsciences  (nasdaq: hscs; hscsw) ("heartsciences" or the "company"), an artificial intelligence (ai)-powered medical technology company focused on transforming ecgs/ekgs to save lives through earlier detection of heart disease, today announced that chief executive officer andrew simpson is scheduled to present at the ld micro invitational xiv conference on tuesday april 9, 2024 at 5:00pm et at the sofitel new york. mr. simpson will also be hosting one-on-one meetings through the conference.

LUXURBAN HOTELS INC. ANNOUNCES 2023 FINANCIAL RESULTS

News

miami--(business wire)--luxurban hotels inc. (or the “company”) (nasdaq: luxh, luxhp), a hospitality company which leases entire existing hotels on a long-term basis and rents rooms in its hotels to business and vacation travelers, including through its partnership with wyndham hotels & resorts (“wyndham”), today announced financial results for full year (“fy 2023”) ended december 31, 2023, including ebitda and adjusted ebitda, which are non-gaap measures and are accompanied by reconciliati.

EFFECTOR THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCE

News

solana beach, calif. and redwood city, calif., april 09, 2024 (globe newswire) -- effector therapeutics, inc. (nasdaq: eftr), a leader in the development of selective translation regulator inhibitors (“stris”) for the treatment of cancer, today announced that the company will present at the stifel virtual oncology forum on tuesday, april 16th at 11:30 am et.

BLM ISSUES NOTICE OF INTENT FOR PARAMOUNT GOLD'S PROPOSED HIGH-GRADE GRASSY MOUNTAIN GOLD AND SILVER MINE

News

winnemucca, nev., march 19, 2024 (globe newswire) -- paramount gold nevada corp. (nyse american: pzg) (“paramount” or the “company”) is pleased to announce that the bureau of land management (“blm”) has filed the notice of intent (the “notice” or “noi”) in the federal registry, thereby initiating the preparation of an environmental impact statement (“eis”) in compliance with the national environmental policy act (“nepa”) process for the proposed grassy mountain mine.